(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Chris A Raanes \u0010President/CEO \u0010Viewray Inc \u0010Will discuss the rollout of their cancer treatment, MRIdian, which can both image, and treat cancer patients at the same time.

Muse Powers Meta to Cusp of $2 Trillion in Best Month Since 2013
18:04

Meta Introduces Palm-Sized Device to Use Muse AI
19:04

Disney+ Price to Jump 13% to $21.49 Per Month
22:21